Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001384101-24-000179
Filing Date
2024-12-04
Accepted
2024-12-04 16:59:18
Documents
1
Period of Report
2024-12-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1733349551.html 4  
1 FORM 4 wk-form4_1733349551.xml 4 3442
  Complete submission text file 0001384101-24-000179.txt   5026
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Issuer) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O GENOMIC HEALTH, INC. 301 PENOBSCOT DRIVE REDWOOD CITY CA 94063
Business Address
Febbo Phillip G. (Reporting) CIK: 0001649245 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36156 | Film No.: 241526899